| 产品详情 |
| Edit |   |
|---|
| Product Name | DPP (IV) Inhibitor Screening Assay Kit |
|---|
| Description | DPP (IV) inhibitors have emerged as a new class of oral antidiabetic agents. These inhibitors promote glucose homeostasis by inhibiting degradation of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) by DPP (IV). GLP-1 extends the action of insulin while suppressing the release of glucagon. Cayman's DPP (IV) Inhibitor Screening Assay provides a convenient fluorescence-based method for screening DPP (IV) inhibitors in a 96-well format. |
|---|
| Size | 96 well |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Dipeptidyl peptidase IV |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 700210-96WELLS |
|---|
| Price | |
|---|
| Order / More Info | DPP (IV) Inhibitor Screening Assay Kit from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|